Summary for Tradename: ZINGO
Clinical Trials for: ZINGO
Tumescent Lidocaine Maximum Safe mg/kg Dosage
Status: Enrolling by invitation Condition: Anesthesia
The Effect of Intravenous Lidocaine and Intraperitoneal Lidocaine Irrigation on Pain After Laparoscopic Cholecystectomy
Status: Recruiting Condition: Postoperative Pain
Lidocaine: Effect of Lidocaine in Chronic Cough
Status: Completed Condition: Chronic Cough
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Status: Completed Condition: Postherpetic Neuralgia; Diabetic Neuropathy; Complex Regional Pain Syndrome; Carpal Tunnel Syndrome; HIV Neuropathy; Idiopathic Sensory Neuropathy; Peripheral Neuropathy
J-Tip® Jet Injection of 1% Buffered Lidocaine or Saline Versus 4% Lidocaine Cream Before Venipuncture or IV Insertion
Status: Terminated Condition: Pain
Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving
Status: Not yet recruiting Condition: Cocaine Addiction
Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult Volunteers
Status: Completed Condition: Healthy
A Dose-response Study of Lidocaine and Etomidate
Status: Completed Condition: Etomidate Overdose of Undetermined Intent
Effect of Intravenous Lidocaine and Dexamethasone Combination on Postoperative Sore Throat, Cough and Hoarseness.
Status: Recruiting Condition: Postoperative Sore Throat, Cough, Hoarseness
A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)
Status: Completed Condition: Morton's Neuroma
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|SYSTEM;INTRADERMAL||022114||Aug 16, 2007||DISCN||No||5,630,796||<disabled>||<disabled>|
|SYSTEM;INTRADERMAL||022114||Aug 16, 2007||DISCN||No||5,899,880||<disabled>||Y||<disabled>|
|SYSTEM;INTRADERMAL||022114||Aug 16, 2007||DISCN||No||6,004,286||<disabled>||Y||<disabled>|
|SYSTEM;INTRADERMAL||022114||Aug 16, 2007||DISCN||No||6,881,200||<disabled>||Y||<disabled>|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639